Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN

Visit https://www.peervoice.com/CWQ860 to view the entire programme with slides. After completing “Carla M. Nester, MD, MSA, FASN - Novel Therapies in Focus: Updates in C3 Glomerulopathy and IC-MPGN”, participants will be able to: Distinguish between the clinical trials examining new and emerging therapies in C3 glomerulopathy (C3G) and immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN); Recognize the mechanistic rationale for targeting the drivers of disease within the complement system in C3G and IC-MPGN; and Evaluate clinical evidence and data regarding emerging therapies in patients with C3G and IC-MPGN.